RNAC
NASDAQ · Biotechnology
Cartesian Therapeutics Inc
$8.84
+0.12 (+1.38%)
Open$8.77
Previous Close$8.72
Day High$8.96
Day Low$8.50
52W High$12.25
52W Low$5.60
Volume—
Avg Volume111.6K
Market Cap267.91M
P/E Ratio—
EPS$-5.80
SectorBiotechnology
Analyst Ratings
Strong Buy
14 analysts
Price Target
+360.0% upside
Current
$8.84
$8.84
Target
$40.66
$40.66
$22.44
$40.66 avg
$45.57
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 3.26M | 11.12M | 132.93M |
| Net Income | -152,042,613 | -466,388,383 | 3.48M |
| Profit Margin | -4,658.6% | -4,425.7% | 2.6% |
| EBITDA | -163,877,377 | -530,618,637 | 5.52M |
| Free Cash Flow | — | — | 2.68M |
| Rev Growth | -70.7% | -70.7% | -1.8% |
| Debt/Equity | 0.28 | 0.28 | 0.86 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $249.46 | -0.54% | 70.2 | 443.23B |
| AMGN | Amgen Inc | $415.21 | -0.63% | 25.8 | 225.90B |
| GILD | Gilead Sciences Inc | $138.36 | +0.16% | — | 169.87B |
| VRTX | Vertex Pharmaceuticals Inc | $505.75 | -2.07% | 30.7 | 135.24B |
| REGN | Regeneron Pharmaceuticals | $803.48 | -0.31% | 19.0 | 82.16B |
| ALNY | Alnylam Pharmaceuticals Inc | $228.65 | +0.67% | 37.6 | 30.39B |